Is aging associated with reduced endothelial nitric oxide availability and impaired endothelial function?

Aging is strongly associated with reduced endothelial nitric oxide (NO) bioavailability and impaired endothelium-dependent vascular function. This relationship is evident even in otherwise healthy older adults and is not explained primarily by reduced vascular smooth-muscle responsiveness.

Clinical and vascular-function evidence

• Human forearm plethysmography studies show that acetylcholine-mediated vasodilation declines with age, while vasodilation to sodium nitroprusside—an exogenous NO donor—is generally preserved. This pattern indicates a predominantly endothelial defect in NO production or preservation.
• A smaller inhibitory effect of the NOS inhibitor L-NMMA in older adults further suggests that endogenous NO contributes less to vasodilation with aging.
• In conduit arteries, brachial artery flow-mediated dilation (FMD) has been reported to be approximately 50% lower in healthy older versus young adults, supporting clinically meaningful age-related endothelial dysfunction.

Mechanistic explanation

• Increased vascular reactive oxygen species (ROS), particularly superoxide, is a supported contributor to vascular aging. Superoxide directly scavenges NO and oxidizes tetrahydrobiopterin (BH₄), an essential eNOS cofactor.
• BH₄ oxidation can cause endothelial NO synthase (eNOS) uncoupling, shifting the enzyme from NO generation toward further superoxide production—a self-amplifying mechanism of endothelial dysfunction.
• Acute improvement in endothelium-dependent dilation after vitamin C or BH₄ in older adults supports oxidative NO loss and impaired eNOS coupling in at least some vascular beds. Increased asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, may contribute in selected populations but is unlikely to be the dominant explanation universally.

Measurement considerations

• The association is most robust for conduit-artery FMD. Reactive hyperemia index findings are less consistent, likely because this measure reflects different, more microvascular physiology and should not be considered interchangeable with FMD.

Bottom line

• For a 71-year-old man, aging itself is a well-supported contributor to lower endothelial NO availability and impaired endothelial vasodilator function, with oxidative stress and eNOS uncoupling central mechanistic explanations.